Technological advancements continue to improve the accuracy and efficacy of imaging studies. Artificial intelligence (AI) is being integrated to enhance image analysis and interpretation. Molecular imaging techniques are evolving, enabling the visualization of cellular processes and the identification of specific cancer markers. Hybrid imaging, such as PET/CT and PET/MRI, combines the strengths of different modalities for more comprehensive evaluations.
